The key to Cid is his ability to “mark” enemies, up to five at a time, by pressing Triangle. Doing so will allow him to deal ...

The reverse stock split is intended to increase the market price per share of the Company’s common stock to regain compliance with the minimum bid continued listing requirement of The Nasdaq Capital ...

We'll still need to keep an eye on Cloud's stamina and temperature when climbing a FFVII Revelation cliff.

Hamaguchi has revealed Final Fantasy 7 Revelation's estimated file size, and it turns out that it would've been too big for a two-disc release.

Naoki Hamaguchi, the director behind the upcoming third and final entry in the Final Fantasy 7 remake trilogy, talks about what type of game he’d want to pursue next. “I do see a lot of fans and ...

Square Enix has shared new information on Final Fantasy 7 Revelation's boss fights during Gamescom Opening Night Live. The highly-anticipated finale to the remake trilogy of the legendary RPG that ...

A seemingly new type of Shiva is joining Final Fantasy VII Revelation. At the game’s New York Comic Con panel, it was ...

It's finally happening. Final Fantasy VII Revelation is headed to consoles and PC on April 8, 2027, according to the latest Sony State of Play livestream event. For the uninitiated, Revelation is the ...

SAUSALITO, Calif., Oct. 25, 2023 /PRNewswire/ -- Revelation Partners today announced the closing of its $608 million Fund IV, far surpassing the healthcare investment firm's initial target of $500 ...

Square Enix has announced a release date for Final Fantasy 7: Revelation, concluding its acclaimed remake trilogy. The third and final chapter in its Final Fantasy 7 remake saga will arrive on April 8 ...

When Was the Book of Revelation Written? It’s an interesting question. Today most scholars date the book of Revelation to late in the first century, during the reign of the Emperor Domitian. According ...

NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (“Revelation”), a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention ...